|
|
||||||||
1The Pulmonary Center, Boston University School of Medicine, Boston 02118; 2The Pulmonary Department, Boston Veterans Administration Medical Center, Boston 02132; 3Department of Pathology, Boston University School of Medicine, Boston 02118; 5Pathology Services, Incorporated, Cambridge, Massachusetts 02139; and 4Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, Maine 04074
Submitted 18 November 2003 ; accepted in final form 12 February 2004
Osteopontin is a multifunctional matricellular protein abundantly expressed during inflammation and repair. Osteopontin deficiency is associated with abnormal wound repair characterized by aberrant collagen fibrillogenesis in the heart and skin. Recent gene microarray studies found that osteopontin is abundantly expressed in both human and mouse lung fibrosis. Macrophages and T cells are known to be major sources of osteopontin. During lung fibrosis, however, osteopontin expression continues to increase when inflammation has receded, suggesting alternative sources of ostepontin during this response. In this study, we demonstrate immunoreactivity for osteopontin in lung epithelial and inflammatory cells in human usual interstitial pneumonitis and murine bleomycin-induced lung fibrosis. After treatment with bleomycin, osteopontin-null mice develop lung fibrosis characterized by dilated distal air spaces and reduced type I collagen expression compared with wild-type controls. There is also a significant decrease in levels of active transforming growth factor-
1 and matrix metalloproteinase-2 in osteopontin null mice. Type III collagen expression and total collagenase activity are similar in both groups. These results demonstrate that osteopontin expression is associated with important fibrogenic signals in the lung and that the epithelium may be an important source of osteopontin during lung fibrosis.
pulmonary fibrosis; type I collagen; matrix metalloproteinase-2; transforming growth factor-
This article has been cited by other articles:
![]() |
S. M. Studer and N. Kaminski Towards Systems Biology of Human Pulmonary Fibrosis Proceedings of the ATS, January 1, 2007; 4(1): 85 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Brass, J. Tomfohr, I. V. Yang, and D. A. Schwartz Using Mouse Genomics to Understand Idiopathic Interstitial Fibrosis Proceedings of the ATS, January 1, 2007; 4(1): 92 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Subramanian, P. Krishnamurthy, K. Singh, and M. Singh Lack of osteopontin improves cardiac function in streptozotocin-induced diabetic mice Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H673 - H683. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Kelly, R. Leigh, S. E. Gilpin, E. Cheng, G. E. M. Martin, K. Radford, G. Cox, and J. Gauldie Cell-specific Gene Expression in Patients with Usual Interstitial Pneumonia Am. J. Respir. Crit. Care Med., September 1, 2006; 174(5): 557 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kaminski and I. O. Rosas Gene expression profiling as a window into idiopathic pulmonary fibrosis pathogenesis: can we identify the right target genes? Proceedings of the ATS, January 1, 2006; 3(4): 339 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Wesselkamper, L. M. Case, L. N. Henning, M. T. Borchers, J. W. Tichelaar, J. M. Mason, N. Dragin, M. Medvedovic, M. A. Sartor, C. R. Tomlinson, et al. Gene Expression Changes during the Development of Acute Lung Injury Role of Transforming Growth Factor {beta} Am. J. Respir. Crit. Care Med., December 1, 2005; 172(11): 1399 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Y. Lee, C. Schroedl, J. K. Brunelle, L. J. Buccellato, O. I. Akinci, H. Kaneto, C. Snyder, J. Eisenbart, G. R. S. Budinger, and N. S. Chandel Bleomycin induces alveolar epithelial cell death through JNK-dependent activation of the mitochondrial death pathway Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L521 - L528. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sahai, P. Malladi, X. Pan, R. Paul, H. Melin-Aldana, R. M. Green, and P. F. Whitington Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin Am J Physiol Gastrointest Liver Physiol, November 1, 2004; 287(5): G1035 - G1043. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |